
Proton beam therapy has been heavily adopted for treating patients with nasopharyngeal cancer, and a high incidence of severe ARD has been reported in this patient population.
Armand Butera is the assistant editor for HCPLive. He attended Fairleigh Dickinson University and graduated with a degree in communications with a concentration in journalism. Prior to graduating, Armand worked as the editor-in-chief of his college newspaper and a radio host for WFDU. He went on to work as a copywriter, freelancer, and human resources assistant before joining HCPLive. In his spare time, he enjoys reading, writing, traveling with his companion and spinning vinyl records. Email him at [email protected].

Proton beam therapy has been heavily adopted for treating patients with nasopharyngeal cancer, and a high incidence of severe ARD has been reported in this patient population.

Though the association between pediatric and parental AD has been detailed in previous literature, differing odds ratios for AD have been recorded throughout the years.

There are 8 biologic therapies currently approved for GPP in Japan, with IL-inhibitors being the predominant therapeutic option.

Between 1980 and 2019 in Spain, a total of 2914 deaths were attributable to SSc, with rates increasing in a 4-year period in the 1980s.

Changes in disease severity were not observed in patients treated with acupuncture or osteopathic medicine, though a reduction in topical corticosteroid use was recorded.

Results from this AoU database study found that Black and Hispanic patients and individuals with physical disabilities were at an increased risk of tinea versicolor.

Reductions in pethidine and diclofenac use was also observed in patients treated with the topical ointment.

Participants defined their acne/acne scars as an “intruder and unwanted companion” in the The Letter to my Disease personification exercise.

Though transgender medicine has existed for over 100 years, physicians like Dr. Jackson Turbeville are still looking for opportunities to make healthcare more accessible and affordable for patients seeking treatment for a variety of dermatologic conditions.

Dr. David Rosmarin details the recent FDA approval of ruxolitinib cream for vitiligo and how the accessibility of the topical therapy could help the roughly one million patients in the US who can't access standard treatment.

Dipeptidyl peptidase-4 inhibitors have been linked to cases of bullous pemphigoid across Japan, prompting investigators to suggest trying DPP-4i discontinuation followed by supportive care.

The novel topical skincare treatment Total Eye was effective in treating periorbital wrinkles, dryness, laxity, and dark circles in patients 35-65 years old.

With this decision, ruxolitinib cream has become the first treatment approved by the FDA for the repigmentation of skin in vitiligo.

Dr. Cohen speaks on combining sun protective measures, such as sunscreen, protective clothing, and antioxidant supplements.

Dr. Lal speaks to how different cultures and different geographical locations can influence UV protection methods, and how sunless tanners can be used to avoid overexposure to UV light outdoors or in tanning beds.

Dr. Craiglow speaks on the public perception of UV safety, how people can best avoid sunburn, and her own personal experience with melanoma and non-melanoma skin cancers.

Dr. Harold Edington gives an overview of Australia's public health campaign regarding UV safety, as well as the lessons Americans can take away from these measures.

New phase 3 data indicates significant improvements in disease severity in children 1-11 years old with eosinophilic esophagitis.

Previous literature indicated a higher prevalence of eczema in children who live in areas with hard water, but this association was not explored in adults until now.

The topical therapy has been under investigation as a first-in-class therapy for this highly contagious skin condition.

Dr. Karan Lal provides an overview of laser therapy for acne, and speaks on the "phenomenal" responses observed in patients with the first and only FDA approved laser treatment, AviClear.

New 21-month data from the SUSTAIN trial found that patients with no history of biologic therapies responded well to secukinumab.

Investigators suggest parents and clinicians should be mindful of children with suspected ACD with a history of exposure to jewelry, clothing, and belts with cobalt.

Investigators suggest confronting sleep difficulties among patients with suicidal ideation through cognitive behavioral intervention could reduce effects of affective reactivity to interpersonal events.

Investigators say the increased risk of emergency room admissions and urgent healthcare use among patients with concomitant AD and asthma warrants a better understanding of disease interplay.

Though a majority of the study population could not identify the condition, certain groups- such as Arab-speaking participants- had a basic knowledge of and positive attitude toward vitiligo.

Previous research has suggested that breathing sounds could be regarded as potential biomarkers for OSA, which could be recorded via the microphones found in most smartphone devices.

Investigators suggest that health care providers have a “unique opportunity” to facilitate shared decision making and empower patients and caregivers by involving them in the practice of eczema care.

Previous research had resulted in conflicting results regarding the drug survival of guselkumab, which was shown to be highest among several biologics featured in this larger study.

Nearly 40% of patients with prurigo nodularis reached clearance or almost-clearance of skin lesions following treatment with nemolizumab.

December 4th 2021

April 16th 2022